| scholarly article | Q13442814 |
| P50 | author | Andrew P Byrnes | Q55193693 |
| P2093 | author name string | Jie Tian | |
| Jeffrey S Smith | |||
| Zhili Xu | |||
| P2860 | cites work | Potent ulcerogenic actions of platelet-activating factor on the stomach | Q59065369 |
| Mechanism of Anaphylactic Death in the Mouse | Q59094648 | ||
| Evidence of a role for paf-acether in the pathophysiology of the shock state | Q62083815 | ||
| Characterization of hemodynamic events following intravascular infusion of recombinant adenovirus reveals possible solutions for mitigating cardiovascular responses | Q64378490 | ||
| Rodent nonclinical safety evaluation studies of SCH 58500, an adenoviral vector for the p53 gene | Q64379227 | ||
| Hypotensive action of IgG preparations containing aggregates is suppressed by PAF-receptor antagonist BN 52021 and by gadolinium chloride (an agent blocking Kupffer cell function) | Q67929057 | ||
| CV-6209, a highly potent antagonist of platelet activating factor in vitro and in vivo | Q69148078 | ||
| Obligatory role of nitric oxide in platelet-activating factor-induced microvascular leakage | Q74341905 | ||
| Splenectomy attenuates superoxide anion release into the hepatic sinusoids after lipopolysaccharide challenge | Q78147843 | ||
| Lifelong elimination of hyperbilirubinemia in the Gunn rat with a single injection of helper-dependent adenoviral vector | Q24555782 | ||
| Essential role of platelet-activating factor receptor in the pathogenesis of Dengue virus infection | Q27489378 | ||
| Elimination of innate immune responses and liver inflammation by PEGylation of adenoviral vectors and methylprednisolone | Q33369785 | ||
| Transient pretreatment with glucocorticoid ablates innate toxicity of systemically delivered adenoviral vectors without reducing efficacy. | Q33382953 | ||
| Platelet activating factor (PAF) involvement in endotoxin-induced thrombocytopenia in rabbits: studies with FR-900452, a specific inhibitor of PAF. | Q33456249 | ||
| Species specificity of the platelet responses to 1-0-alkyl-2-acetyl-sn-glycero-3-phosphocholine | Q33484231 | ||
| Acetyl glyceryl ether phosphorylcholine. Intravascular alterations following intravenous infusion into the baboon | Q33486402 | ||
| Cancer-induced expansion and activation of CD11b+ Gr-1+ cells predispose mice to adenoviral-triggered anaphylactoid-type reactions | Q33713324 | ||
| Role of platelet-activating factor in cardiovascular pathophysiology. | Q34051712 | ||
| Platelet-activating factor mediates hemodynamic changes and lung injury in endotoxin-treated rats | Q34572515 | ||
| Platelet-activating factor, PAF acetylhydrolase, and severe anaphylaxis | Q34586645 | ||
| Adenovirus vector induced innate immune responses: impact upon efficacy and toxicity in gene therapy and vaccine applications | Q34717992 | ||
| Lexipafant and acute pancreatitis: a critical appraisal of the clinical trials | Q35003210 | ||
| Intravascular adenoviral agents in cancer patients: lessons from clinical trials | Q35043094 | ||
| Platelet-activating factor, a pleiotrophic mediator of physiological and pathological processes | Q35621992 | ||
| Influence of method of systemic administration of adenovirus on virus-mediated toxicity: focus on mortality, virus distribution, and drug metabolism | Q36395442 | ||
| Comparison of adenoviruses from species B, C, E, and F after intravenous delivery | Q38297861 | ||
| Replication-attenuated Human Adenoviral Type 4 vectors elicit capsid dependent enhanced innate immune responses that are partially dependent upon interactions with the complement system | Q40012391 | ||
| Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications | Q40701479 | ||
| Biosynthesis of platelet-activating factor by cultured rat Kupffer cells stimulated with calcium ionophore A23187. | Q41780241 | ||
| Role of PAF receptors during intestinal ischemia and reperfusion injury. A comparative study between PAF receptor-deficient mice and PAF receptor antagonist treatment | Q41886673 | ||
| Pharmacological investigation of the mechanisms of platelet-activating factor induced mortality in the mouse | Q41916597 | ||
| Effects of inhibitors of arachidonic acid metabolism on Paf-induced gastric mucosal necrosis and haemoconcentration | Q42075404 | ||
| Study of the effector mechanism involved in the production of haemorrhagic necrosis of the small intestine in rat passive anaphylaxis. | Q42279611 | ||
| Pharmacology of ABT-491, a highly potent platelet-activating factor receptor antagonist | Q42549572 | ||
| Pathways of anaphylaxis in the mouse | Q43952644 | ||
| A hemodynamic response to intravenous adenovirus vector particles is caused by systemic Kupffer cell-mediated activation of endothelial cells | Q44535618 | ||
| A quantitative assay for measuring clearance of adenovirus vectors by Kupffer cells. | Q44662326 | ||
| Acute toxicity after high-dose systemic injection of helper-dependent adenoviral vectors into nonhuman primates. | Q44765402 | ||
| Rapid Kupffer cell death after intravenous injection of adenovirus vectors | Q45119497 | ||
| Cirrhotic rat livers with extensive fibrosis can be safely transduced with clinical-grade adenoviral vectors. Evidence of cirrhosis reversion | Q45158832 | ||
| Unexpected pulmonary uptake of adenovirus vectors in animals with chronic liver disease | Q45872936 | ||
| Wild-type adenoviruses from groups A-F evoke unique innate immune responses, of which HAd3 and SAd23 are partially complement dependent | Q45875332 | ||
| Porcine toxicology studies of SCH 58500, an adenoviral vector for the p53 gene | Q45882937 | ||
| Simple method for quantitation of enhanced vascular permeability. | Q46605899 | ||
| Validation of volume-pressure recording tail-cuff blood pressure measurements | Q47304414 | ||
| Severe pulmonary pathology after intravenous administration of vectors in cirrhotic rats | Q47353872 | ||
| PAF increases vascular permeability in selected tissues: effect of BN-52021 and L-655,240. | Q50893420 | ||
| Role of leukotrienes revealed by targeted disruption of the 5-lipoxygenase gene. | Q52512619 | ||
| Vascular actions of synthetic PAF-acether (a synthetic platelet-activating factor) in the rat: evidence for a platelet independent mechanism. | Q54519052 | ||
| Splenectomy alters Kupffer cell response to endotoxin. | Q54752214 | ||
| P433 | issue | 3 | |
| P921 | main subject | Adenoviridae | Q193447 |
| P304 | page(s) | 609-616 | |
| P577 | publication date | 2009-12-01 | |
| P1433 | published in | Molecular Therapy | Q15762400 |
| P1476 | title | Induction of shock after intravenous injection of adenovirus vectors: a critical role for platelet-activating factor | |
| P478 | volume | 18 |
| Q38961417 | A novel pancreatropic coxsackievirus vector expressing glucagon-like peptide 1 reduces hyperglycemia in streptozotocin-treated mice |
| Q38187126 | Adenovirus-triggered innate signalling pathways |
| Q47300209 | And Then There Was Light: Perspectives of Optogenetics for Deep Brain Stimulation and Neuromodulation |
| Q50977875 | Challenges and Prospects for Helper-Dependent Adenoviral Vector-Mediated Gene Therapy. |
| Q55452882 | Gene-Therapeutic Strategies Targeting Angiogenesis in Peripheral Artery Disease. |
| Q34982825 | Helper-dependent adenoviral vectors for liver-directed gene therapy. |
| Q35126751 | IL-1α and complement cooperate in triggering local neutrophilic inflammation in response to adenovirus and eliminating virus-containing cells |
| Q35800342 | Intratumoral delivery of CD154 homolog (Ad-ISF35) induces tumor regression: analysis of vector biodistribution, persistence and gene expression |
| Q42285876 | Preclinical safety evaluation of rAd5-hTERTC27 by intravenous injection |
Search more.